|제목||2022 KDDF-SNU Science Conference / Poster|
2022 KDDF (Korea Drug Development Fund) - SNU (Seoul National University)
Dr. Jin-San Yoo, CEO of PharmAbcine, delivered a poster presentation on the nonclinical data of the company’s early-stage anti-EGFRviii antibody (PMC-005) between August 25th and 27th.
> The image below is the nonclinical data of PMC-005.
■ Posters for other pipelines are available for viewing.